Impact of Expanded Access on FDA Regulatory Action and Product Labeling Article Swipe
Jonathan P. Jarow
,
Richard Moscicki
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1177/2168479017707800
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1177/2168479017707800
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1177/2168479017707800
- OA Status
- green
- Cited By
- 19
- References
- 7
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2610577735
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2610577735Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/2168479017707800Digital Object Identifier
- Title
-
Impact of Expanded Access on FDA Regulatory Action and Product LabelingWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-05-03Full publication date if available
- Authors
-
Jonathan P. Jarow, Richard MoscickiList of authors in order
- Landing page
-
https://doi.org/10.1177/2168479017707800Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/6075680Direct OA link when available
- Concepts
-
Expanded access, Adverse effect, Market access, Medicine, Drug, Product (mathematics), Regulatory science, Pharmacy, Business, Drug development, New product development, Pharmacology, Marketing, Family medicine, Oncology, Pathology, Ecology, Mathematics, Geometry, Biology, AgricultureTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
19Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 1, 2023: 2, 2022: 4, 2021: 3Per-year citation counts (last 5 years)
- References (count)
-
7Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2610577735 |
|---|---|
| doi | https://doi.org/10.1177/2168479017707800 |
| ids.doi | https://doi.org/10.1177/2168479017707800 |
| ids.mag | 2610577735 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/30079277 |
| ids.openalex | https://openalex.org/W2610577735 |
| fwci | 1.16000129 |
| mesh[0].qualifier_ui | Q000706 |
| mesh[0].descriptor_ui | D017277 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | statistics & numerical data |
| mesh[0].descriptor_name | Drug Approval |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D004335 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Drug and Narcotic Control |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D064420 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Drug-Related Side Effects and Adverse Reactions |
| mesh[3].qualifier_ui | Q000706 |
| mesh[3].descriptor_ui | D006297 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | statistics & numerical data |
| mesh[3].descriptor_name | Health Services Accessibility |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006801 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Humans |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D011356 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Product Labeling |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D014481 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | United States |
| mesh[7].qualifier_ui | Q000706 |
| mesh[7].descriptor_ui | D014486 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | statistics & numerical data |
| mesh[7].descriptor_name | United States Food and Drug Administration |
| mesh[8].qualifier_ui | Q000706 |
| mesh[8].descriptor_ui | D017277 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | statistics & numerical data |
| mesh[8].descriptor_name | Drug Approval |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D004335 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Drug and Narcotic Control |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D064420 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Drug-Related Side Effects and Adverse Reactions |
| mesh[11].qualifier_ui | Q000706 |
| mesh[11].descriptor_ui | D006297 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | statistics & numerical data |
| mesh[11].descriptor_name | Health Services Accessibility |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D011356 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Product Labeling |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D014481 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | United States |
| mesh[15].qualifier_ui | Q000706 |
| mesh[15].descriptor_ui | D014486 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | statistics & numerical data |
| mesh[15].descriptor_name | United States Food and Drug Administration |
| mesh[16].qualifier_ui | Q000706 |
| mesh[16].descriptor_ui | D017277 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | statistics & numerical data |
| mesh[16].descriptor_name | Drug Approval |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D004335 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Drug and Narcotic Control |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D064420 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Drug-Related Side Effects and Adverse Reactions |
| mesh[19].qualifier_ui | Q000706 |
| mesh[19].descriptor_ui | D006297 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | statistics & numerical data |
| mesh[19].descriptor_name | Health Services Accessibility |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D006801 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Humans |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D011356 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Product Labeling |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D014481 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | United States |
| mesh[23].qualifier_ui | Q000706 |
| mesh[23].descriptor_ui | D014486 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | statistics & numerical data |
| mesh[23].descriptor_name | United States Food and Drug Administration |
| type | article |
| title | Impact of Expanded Access on FDA Regulatory Action and Product Labeling |
| biblio.issue | 6 |
| biblio.volume | 51 |
| biblio.last_page | 789 |
| biblio.first_page | 787 |
| topics[0].id | https://openalex.org/T13417 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994000196456909 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2737 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Biomedical Ethics and Regulation |
| topics[1].id | https://openalex.org/T11792 |
| topics[1].field.id | https://openalex.org/fields/20 |
| topics[1].field.display_name | Economics, Econometrics and Finance |
| topics[1].score | 0.9980000257492065 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2002 |
| topics[1].subfield.display_name | Economics and Econometrics |
| topics[1].display_name | Pharmaceutical Economics and Policy |
| topics[2].id | https://openalex.org/T10804 |
| topics[2].field.id | https://openalex.org/fields/20 |
| topics[2].field.display_name | Economics, Econometrics and Finance |
| topics[2].score | 0.9952999949455261 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2002 |
| topics[2].subfield.display_name | Economics and Econometrics |
| topics[2].display_name | Health Systems, Economic Evaluations, Quality of Life |
| is_xpac | False |
| apc_list.value | 2790 |
| apc_list.currency | EUR |
| apc_list.value_usd | 3590 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2775832928 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8110620975494385 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q407954 |
| concepts[0].display_name | Expanded access |
| concepts[1].id | https://openalex.org/C197934379 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5575787425041199 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[1].display_name | Adverse effect |
| concepts[2].id | https://openalex.org/C2777481183 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5141082406044006 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q6770787 |
| concepts[2].display_name | Market access |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.5029663443565369 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C2780035454 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5000829696655273 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[4].display_name | Drug |
| concepts[5].id | https://openalex.org/C90673727 |
| concepts[5].level | 2 |
| concepts[5].score | 0.48201146721839905 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q901718 |
| concepts[5].display_name | Product (mathematics) |
| concepts[6].id | https://openalex.org/C2778917124 |
| concepts[6].level | 2 |
| concepts[6].score | 0.47237685322761536 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7309705 |
| concepts[6].display_name | Regulatory science |
| concepts[7].id | https://openalex.org/C104863432 |
| concepts[7].level | 2 |
| concepts[7].score | 0.45048969984054565 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q614304 |
| concepts[7].display_name | Pharmacy |
| concepts[8].id | https://openalex.org/C144133560 |
| concepts[8].level | 0 |
| concepts[8].score | 0.44905638694763184 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q4830453 |
| concepts[8].display_name | Business |
| concepts[9].id | https://openalex.org/C64903051 |
| concepts[9].level | 3 |
| concepts[9].score | 0.44026973843574524 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2198549 |
| concepts[9].display_name | Drug development |
| concepts[10].id | https://openalex.org/C19351080 |
| concepts[10].level | 2 |
| concepts[10].score | 0.4113110899925232 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1395034 |
| concepts[10].display_name | New product development |
| concepts[11].id | https://openalex.org/C98274493 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3654841184616089 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[11].display_name | Pharmacology |
| concepts[12].id | https://openalex.org/C162853370 |
| concepts[12].level | 1 |
| concepts[12].score | 0.29011571407318115 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q39809 |
| concepts[12].display_name | Marketing |
| concepts[13].id | https://openalex.org/C512399662 |
| concepts[13].level | 1 |
| concepts[13].score | 0.14858156442642212 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[13].display_name | Family medicine |
| concepts[14].id | https://openalex.org/C143998085 |
| concepts[14].level | 1 |
| concepts[14].score | 0.1437591314315796 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[14].display_name | Oncology |
| concepts[15].id | https://openalex.org/C142724271 |
| concepts[15].level | 1 |
| concepts[15].score | 0.09612366557121277 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[15].display_name | Pathology |
| concepts[16].id | https://openalex.org/C18903297 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7150 |
| concepts[16].display_name | Ecology |
| concepts[17].id | https://openalex.org/C33923547 |
| concepts[17].level | 0 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q395 |
| concepts[17].display_name | Mathematics |
| concepts[18].id | https://openalex.org/C2524010 |
| concepts[18].level | 1 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q8087 |
| concepts[18].display_name | Geometry |
| concepts[19].id | https://openalex.org/C86803240 |
| concepts[19].level | 0 |
| concepts[19].score | 0.0 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[19].display_name | Biology |
| concepts[20].id | https://openalex.org/C118518473 |
| concepts[20].level | 2 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q11451 |
| concepts[20].display_name | Agriculture |
| keywords[0].id | https://openalex.org/keywords/expanded-access |
| keywords[0].score | 0.8110620975494385 |
| keywords[0].display_name | Expanded access |
| keywords[1].id | https://openalex.org/keywords/adverse-effect |
| keywords[1].score | 0.5575787425041199 |
| keywords[1].display_name | Adverse effect |
| keywords[2].id | https://openalex.org/keywords/market-access |
| keywords[2].score | 0.5141082406044006 |
| keywords[2].display_name | Market access |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.5029663443565369 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/drug |
| keywords[4].score | 0.5000829696655273 |
| keywords[4].display_name | Drug |
| keywords[5].id | https://openalex.org/keywords/product |
| keywords[5].score | 0.48201146721839905 |
| keywords[5].display_name | Product (mathematics) |
| keywords[6].id | https://openalex.org/keywords/regulatory-science |
| keywords[6].score | 0.47237685322761536 |
| keywords[6].display_name | Regulatory science |
| keywords[7].id | https://openalex.org/keywords/pharmacy |
| keywords[7].score | 0.45048969984054565 |
| keywords[7].display_name | Pharmacy |
| keywords[8].id | https://openalex.org/keywords/business |
| keywords[8].score | 0.44905638694763184 |
| keywords[8].display_name | Business |
| keywords[9].id | https://openalex.org/keywords/drug-development |
| keywords[9].score | 0.44026973843574524 |
| keywords[9].display_name | Drug development |
| keywords[10].id | https://openalex.org/keywords/new-product-development |
| keywords[10].score | 0.4113110899925232 |
| keywords[10].display_name | New product development |
| keywords[11].id | https://openalex.org/keywords/pharmacology |
| keywords[11].score | 0.3654841184616089 |
| keywords[11].display_name | Pharmacology |
| keywords[12].id | https://openalex.org/keywords/marketing |
| keywords[12].score | 0.29011571407318115 |
| keywords[12].display_name | Marketing |
| keywords[13].id | https://openalex.org/keywords/family-medicine |
| keywords[13].score | 0.14858156442642212 |
| keywords[13].display_name | Family medicine |
| keywords[14].id | https://openalex.org/keywords/oncology |
| keywords[14].score | 0.1437591314315796 |
| keywords[14].display_name | Oncology |
| keywords[15].id | https://openalex.org/keywords/pathology |
| keywords[15].score | 0.09612366557121277 |
| keywords[15].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1177/2168479017707800 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S1037458212 |
| locations[0].source.issn | 2168-4790, 2168-4804 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2168-4790 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Therapeutic Innovation & Regulatory Science |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Therapeutic Innovation & Regulatory Science |
| locations[0].landing_page_url | https://doi.org/10.1177/2168479017707800 |
| locations[1].id | pmid:30079277 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Therapeutic innovation & regulatory science |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/30079277 |
| locations[2].id | pmh:oai:europepmc.org:5024773 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://europepmc.org/pmc/articles/PMC6075680 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:6075680 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Ther Innov Regul Sci |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6075680 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5110483882 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Jonathan P. Jarow |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1320320070, https://openalex.org/I1333606569 |
| authorships[0].affiliations[0].raw_affiliation_string | Office of the Center Director, Center for Drug Evaluation and Research, US Food and Drug Administration, WO51 RM6364, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA |
| authorships[0].institutions[0].id | https://openalex.org/I1333606569 |
| authorships[0].institutions[0].ror | https://ror.org/00yf3tm42 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070, https://openalex.org/I1333606569 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Center for Drug Evaluation and Research |
| authorships[0].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[0].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[0].institutions[1].type | government |
| authorships[0].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | United States Food and Drug Administration |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jonathan P. Jarow |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Office of the Center Director, Center for Drug Evaluation and Research, US Food and Drug Administration, WO51 RM6364, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA |
| authorships[1].author.id | https://openalex.org/A5075909555 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Richard Moscicki |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1320320070, https://openalex.org/I1333606569 |
| authorships[1].affiliations[0].raw_affiliation_string | Office of the Center Director, Center for Drug Evaluation and Research, US Food and Drug Administration, WO51 RM6364, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA |
| authorships[1].institutions[0].id | https://openalex.org/I1333606569 |
| authorships[1].institutions[0].ror | https://ror.org/00yf3tm42 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070, https://openalex.org/I1333606569 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Center for Drug Evaluation and Research |
| authorships[1].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[1].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[1].institutions[1].type | government |
| authorships[1].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | United States Food and Drug Administration |
| authorships[1].author_position | last |
| authorships[1].raw_author_name | Richard Moscicki |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Office of the Center Director, Center for Drug Evaluation and Research, US Food and Drug Administration, WO51 RM6364, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6075680 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Impact of Expanded Access on FDA Regulatory Action and Product Labeling |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T13417 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994000196456909 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2737 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Biomedical Ethics and Regulation |
| related_works | https://openalex.org/W2945724922, https://openalex.org/W2270002876, https://openalex.org/W3211798705, https://openalex.org/W4245533983, https://openalex.org/W2809081408, https://openalex.org/W2589716039, https://openalex.org/W2462743774, https://openalex.org/W4296163696, https://openalex.org/W1537699525, https://openalex.org/W2134695639 |
| cited_by_count | 19 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 2 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 4 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 3 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 6 |
| locations_count | 4 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:6075680 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Ther Innov Regul Sci |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6075680 |
| primary_location.id | doi:10.1177/2168479017707800 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S1037458212 |
| primary_location.source.issn | 2168-4790, 2168-4804 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2168-4790 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Therapeutic Innovation & Regulatory Science |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Therapeutic Innovation & Regulatory Science |
| primary_location.landing_page_url | https://doi.org/10.1177/2168479017707800 |
| publication_date | 2017-05-03 |
| publication_year | 2017 |
| referenced_works | https://openalex.org/W2462016537, https://openalex.org/W2556422387, https://openalex.org/W1906263797, https://openalex.org/W2054603277, https://openalex.org/W2325752802, https://openalex.org/W4298863066, https://openalex.org/W2262503802 |
| referenced_works_count | 7 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 90 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 2 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.4300000071525574 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.73424902 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |